Chondrogenic gene expression

Chondrogenic gene expression refers to the orchestrated transcription of a set of genes involved in the process of chondrogenesis, the developmental program by which mesenchymal stem or progenitor cells differentiate into chondrocytes and produce cartilage. Key canonical genes and markers in this process include the transcription factor SOX9, as well as ECM components such as collagen type II (COL2A1) and aggrecan (ACAN). The temporal and spatial expression of these genes underpins cartilage formation, repair, and diseases such as osteoarthritis and chondrosarcoma. Chondrogenic gene expression patterns are widely used as biomarkers for the assessment of cartilage differentiation and are crucial for regenerative medicine and cartilage engineering research[5][3][6][4][1].\n\nThis entry does not correspond to a single molecular drug target and should not be classified as a therapeutic target molecule. Instead, it is a biological process or signature involving several genes and pathways.

Other names

chondrogenic differentiation signaturechondrogenesis marker geneschondrocyte gene expression profilechondrogenic markers